All May Use “One for All” — But None May Own It
In a recent decision, the Delhi High Court dismissed an appeal by Oswaal Books and Learnings Private Limited (“Oswaal Books”) challenging the refusal of their trademark application for…
3,126 articles
In a recent decision, the Delhi High Court dismissed an appeal by Oswaal Books and Learnings Private Limited (“Oswaal Books”) challenging the refusal of their trademark application for…
In this week’s IP-Astro edition, we explore how each zodiac sign might approach shared IP issues—from joint ownership to licensing—under Gemini’s collaborative influence. These reflections offer a light-hearted,…
The Calcutta High Court set aside the rejection of a patent application filed by UPL Ltd., involving innovative fungicidal combinations. The Court found that the rejection order issued…
The Madras High Court has overturned the rejection of a patent on a carbon capture process, citing the Patent Office's failure to adequately justify its decision and its…
In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to…
In a recent decision, the Delhi High Court granted an interim injunction in favour of Under Armour Inc. against Indian apparel entity Anish Agarwal & Anr., restraining the…
After securing interim relief in a defamation case involving a viral YouTube video, Isha Foundation awaits further proceedings now adjourned to 9th September 2025. No significant development occurred…
The Calcutta High Court remanded a patent application back to the Controller of Patents, citing infrimities in evaluating claim amendments. The Court stressed that mere change in claim…
In this week’s IP-Astro edition, we explore how each zodiac sign might approach shared IP issues—from joint ownership to licensing—under Gemini’s collaborative influence. These reflections offer a light-hearted,…
The Delhi High Court confirmed that once a patent grant order is signed, a pre-grant opposition under Section 25(1) is no longer valid. This case involving Vertex Pharmaceuticals…